Cover Image
市場調查報告書

免疫球蛋白E (IgE) 過敏血液檢驗:醫療設備的開發平台評估

Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2018

出版商 GlobalData 商品編碼 666935
出版日期 內容資訊 英文 67 Pages
訂單完成後即時交付
價格
Back to Top
免疫球蛋白E (IgE) 過敏血液檢驗:醫療設備的開發平台評估 Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2018
出版日期: 2018年07月06日 內容資訊: 英文 67 Pages
簡介

本報告提供全球IgE過敏血液檢驗市場上的主要開發中產品及其臨床實驗進展調查,並彙整產品的功能·特性比較分析 (臨床實驗的各進展階段) ,及主要企業·組織的簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 免疫球蛋白E (IgE) 過敏血液檢驗概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期

第4章 IgE過敏血液檢驗:臨床實驗中的開發中產品,各企業

  • IgE過敏血液檢驗的企業:各臨床實驗階段的開發中產品
  • IgE過敏血液檢驗:各臨床實驗階段的開發中產品

第5章 IgE過敏血液檢驗市場:企業·產品概要

  • Abionic SA
  • Amerimmune
  • AXO Science SAS
  • Biovator AB (Inactive)
  • Children's Hospital Boston
  • China Medical Technologies Inc (Inactive)
  • Cytognos, SL
  • EUROIMMUN US LLC
  • Ferrer inCode SL
  • HOB Biotech Group Suzhou Co Ltd
  • Hycor Biomedical Inc
  • Institut fur Produktqualitat GmbH
  • IRCCS San Raffaele Hospital
  • Medical Research Council
  • Stanford University
  • Thermo Fisher Scientific Inc
  • University of Connecticut Health Center
  • University of Nottingham
  • University of Queensland
  • VEGA Ltd

第6章 IgE過敏血液檢驗市場:目前的趨勢

第7章 附錄

目錄
Product Code: GDME0654EPD

GlobalData's Medical Devices sector report, "Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Immunoglobulin E (IgE) Allergy Blood Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunoglobulin E (IgE) Allergy Blood Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Immunoglobulin E (IgE) Allergy Blood Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunoglobulin E (IgE) Allergy Blood Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunoglobulin E (IgE) Allergy Blood Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Immunoglobulin E (IgE) Allergy Blood Tests Overview 6

3 Products under Development 7

  • 3.1 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development 7
  • 3.2 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Segment 8
  • 3.3 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Territory 9
  • 3.4 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Regulatory Path 10
  • 3.5 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Estimated Approval Date 11

4 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products under Development by Companies 12

  • 4.1 Immunoglobulin E (IgE) Allergy Blood Tests Companies - Pipeline Products by Stage of Development 12
  • 4.2 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development 13

5 Immunoglobulin E (IgE) Allergy Blood Tests Companies and Product Overview 14

  • 5.1 Abionic SA Company Overview 14
  • 5.2 Amerimmune Company Overview 16
  • 5.3 AXO Science SAS Company Overview 18
  • 5.4 Biovator AB (Inactive) Company Overview 19
  • 5.5 Children's Hospital Boston Company Overview 20
  • 5.6 China Medical Technologies Inc (Inactive) Company Overview 22
  • 5.7 Cytognos, SL Company Overview 23
  • 5.8 EUROIMMUN US LLC Company Overview 24
  • 5.9 Ferrer inCode SL Company Overview 26
  • 5.10 HOB Biotech Group Suzhou Co Ltd Company Overview 27
  • 5.11 Hycor Biomedical Inc Company Overview 28
  • 5.12 Institut fur Produktqualitat GmbH Company Overview 30
  • 5.13 IRCCS San Raffaele Hospital Company Overview 31
  • 5.14 Medical Research Council Company Overview 32
  • 5.15 Stanford University Company Overview 33
  • 5.16 Thermo Fisher Scientific Inc Company Overview 34
  • 5.17 University of Connecticut Health Center Company Overview 35
  • 5.18 University of Nottingham Company Overview 36
  • 5.19 University of Queensland Company Overview 37
  • 5.20 VEGA Ltd Company Overview 38

6 Immunoglobulin E (IgE) Allergy Blood Tests- Recent Developments 39

  • 6.1 Jul 02, 2018: Arrayit Completes Allergy Testing Pilot Program for One of the Nation's Largest Retail Chains 39
  • 6.2 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 39
  • 6.3 May 10, 2018: Researchers develop a new test to safely and accurately diagnose peanut allergies 40
  • 6.4 May 08, 2018: Omega Diagnostics Group Announced CE-Mark for Allersys 40
  • 6.5 May 03, 2018: Scientists develop a new test to safely and accurately diagnose peanut allergies 40
  • 6.6 May 03, 2018: Siemens Healthineers fully on track to meet the targets 42
  • 6.7 Apr 25, 2018: Thermo Fisher Scientific Reports First Quarter 2018 Results 43
  • 6.8 Apr 10, 2018: Theradiag reports its 2017 annual results and sales for first quarter 2018 44
  • 6.9 Mar 16, 2018: Thermo Fisher Scientific Announces Plans To Build State-Of-The-Art Pharma Services Facility In Rheinfelden 46
  • 6.10 Feb 20, 2018: Theradiag Announces 2017 Annual Sales and Cash Flow at End 2017 47
  • 6.11 Feb 15, 2018: NuVision follows its vision with £500,000 investment 48
  • 6.12 Jan 31, 2018: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2017 Results 48
  • 6.13 Jan 31, 2018: Thermo Fisher Scientific Uses Tax Reform Benefit to Make Additional Investments in Colleagues, Customers and Communities 51
  • 6.14 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics 51
  • 6.15 Dec 29, 2017: Thermo Fisher Scientific Completes Acquisition of Phenom-World 52
  • 6.16 Dec 21, 2017: Omega Diagnostics Group Receives CE-Mark for Allersys 52
  • 6.17 Dec 19, 2017: THERADIAG provides an update on Prestizia and its partnership with HOB Biotech 52
  • 6.18 Dec 06, 2017: Abionic Announces Appointment of Leading Diagnostics Industry Experts to Board of Directors 53
  • 6.19 Nov 29, 2017: Siemens plans to list Siemens Healthineers on Frankfurt Stock Exchange 53
  • 6.20 Oct 26, 2017: Theradiag: Revenues at the end of September 30, 2017 54
  • 6.21 Oct 25, 2017: Thermo Fisher Scientific Reports Third Quarter 2017 Results 54
  • 6.22 Oct 20, 2017: Abionic Announces FDA Registration for World's Most Rapid Allergy Test and abioSCOPE Diagnostic Testing Platform 57
  • 6.23 Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results 58
  • 6.24 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 60
  • 6.25 Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 62
  • 6.26 Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 62

7 Appendix 64

  • 7.1 Methodology 64
  • 7.2 About GlobalData 67
  • 7.3 Contact Us 67
  • 7.4 Disclaimer 67

1.1 List of Tables

  • Table 1: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development 7
  • Table 2: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Segment 8
  • Table 3: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Territory 9
  • Table 4: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Regulatory Path 10
  • Table 5: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Estimated Approval Date 11
  • Table 6: Immunoglobulin E (IgE) Allergy Blood Tests Companies - Pipeline Products by Stage of Development 12
  • Table 7: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development 13
  • Table 8: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 14
  • Table 9: abioKIT-a - 6 Tests In 12 Min - Product Status 14
  • Table 10: abioKIT-a - 6 Tests In 12 Min - Product Description 14
  • Table 11: IVD CAPSULE Aeroallergens - Product Status 15
  • Table 12: IVD CAPSULE Aeroallergens - Product Description 15
  • Table 13: Amerimmune Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 14: Basophile Panel - Product Status 16
  • Table 15: Basophile Panel - Product Description 16
  • Table 16: CD69 and IgE Receptor Expression Assay - Product Status 17
  • Table 17: CD69 and IgE Receptor Expression Assay - Product Description 17
  • Table 18: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 19: Diagnostic Test - Allergy - Product Status 18
  • Table 20: Diagnostic Test - Allergy - Product Description 18
  • Table 21: Biovator AB (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 22: Cytokine Profile Assay - Product Status 19
  • Table 23: Cytokine Profile Assay - Product Description 19
  • Table 24: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 25: Biomarker Assay - Allergy - Product Status 20
  • Table 26: Biomarker Assay - Allergy - Product Description 21
  • Table 27: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 28: Diagnostic Assay - Total IgE - Product Status 22
  • Table 29: Diagnostic Assay - Total IgE - Product Description 22
  • Table 30: Cytognos, SL Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 31: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Status 23
  • Table 32: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Description 23
  • Table 33: EUROIMMUN US LLC Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 34: IgE Allergy Test - DP 3134-1601-1 E - Product Status 24
  • Table 35: IgE Allergy Test - DP 3134-1601-1 E - Product Description 24
  • Table 36: IgE Allergy Test - DP 3134-1601-2 E - Product Status 25
  • Table 37: IgE Allergy Test - DP 3134-1601-2 E - Product Description 25
  • Table 38: Ferrer inCode SL Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 39: DAP - Product Status 26
  • Table 40: DAP - Product Description 26
  • Table 41: HOB Biotech Group Suzhou Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 42: HOB Biotech Diagnostic Assay - Allergy - Product Status 27
  • Table 43: HOB Biotech Diagnostic Assay - Allergy - Product Description 27
  • Table 44: Hycor Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 45: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Status 28
  • Table 46: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Description 28
  • Table 47: HYTEC 288 PLUS - Tryptase Test - Product Status 29
  • Table 48: HYTEC 288 PLUS - Tryptase Test - Product Description 29
  • Table 49: Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 50: Diagnostic Test - Allergy - Product Status 30
  • Table 51: Diagnostic Test - Allergy - Product Description 30
  • Table 52: IRCCS San Raffaele Hospital Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 53: Diagnostic Test - Allergic Asthma - Product Status 31
  • Table 54: Diagnostic Test - Allergic Asthma - Product Description 31
  • Table 55: Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 56: Mast Activation Test - Product Status 32
  • Table 57: Mast Activation Test - Product Description 32
  • Table 58: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 59: Basophil Activation Test - Product Status 33
  • Table 60: Basophil Activation Test - Product Description 33
  • Table 61: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 62: Diagnostic Test - Allergy - Product Status 34
  • Table 63: Diagnostic Test - Allergy - Product Description 34
  • Table 64: University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 65: Ultrasensitive Peanut Allergy Test - Product Status 35
  • Table 66: Ultrasensitive Peanut Allergy Test - Product Description 35
  • Table 67: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 68: Allergy Test - Product Status 36
  • Table 69: Allergy Test - Product Description 36
  • Table 70: University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 71: Diagnostic Assay - Allergy - Product Status 37
  • Table 72: Diagnostic Assay - Allergy - Product Description 37
  • Table 73: VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 74: Microarray Based Allergen Diagnostic Kit - Product Status 38
  • Table 75: Microarray Based Allergen Diagnostic Kit - Product Description 38
  • Table 76: Glossary 66

1.2 List of Figures

  • Figure 1: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development 7
  • Figure 2: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Segment 8
  • Figure 3: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Territory 9
  • Figure 4: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Regulatory Path 10
  • Figure 5: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Estimated Approval Date 11
Back to Top